Cargando…
Serum metabolomics identified specific lipid compounds which may serve as markers of disease progression in patients with Alström and Bardet-Biedl syndromes
Objectives: Alström syndrome (ALMS) and Bardet-Biedl syndrome (BBS) are among the so-called ciliopathies and are associated with the development of multiple systemic abnormalities, including early childhood obesity and progressive neurodegeneration. Given the progressive deterioration of patients’ q...
Autores principales: | Jeziorny, Krzysztof, Pietrowska, Karolina, Sieminska, Julia, Zmyslowska-Polakowska, Ewa, Kretowski, Adam, Ciborowski, Michal, Zmyslowska, Agnieszka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10657895/ https://www.ncbi.nlm.nih.gov/pubmed/38028552 http://dx.doi.org/10.3389/fmolb.2023.1251905 |
Ejemplares similares
-
Identification of bone metabolism disorders in patients with Alström and Bardet-Biedl syndromes based on markers of bone turnover and mandibular atrophy
por: Jeziorny, Krzysztof, et al.
Publicado: (2022) -
Searching for Effective Methods of Diagnosing Nervous System Lesions in Patients with Alström and Bardet–Biedl Syndromes
por: Waszczykowska, Arleta, et al.
Publicado: (2023) -
Association of circulating miRNAS in patients with Alstrőm and Bardet-Biedl syndromes with clinical course parameters
por: Zmyslowska, Agnieszka, et al.
Publicado: (2022) -
Proteomic and Transcriptomic Landscapes of Alström and Bardet–Biedl Syndromes
por: Smyczynska, Urszula, et al.
Publicado: (2022) -
Next-Generation Sequencing in the Diagnosis of Patients with Bardet–Biedl Syndrome—New Variants and Relationship with Hyperglycemia and Insulin Resistance
por: Jeziorny, Krzysztof, et al.
Publicado: (2020)